Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
Crossref DOI link: https://doi.org/10.1186/s12885-016-2302-5
Published Online: 2016-04-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brodsky, Alexander S.
Xiong, Jinjun
Yang, Dongfang
Schorl, Christoph
Fenton, Mary Anne
Graves, Theresa A.
Sikov, William M.
Resnick, Murray B.
Wang, Yihong
Funding for this research was provided by:
Mary Kay Foundation